Enhertu 100 mg lyophilized powder for injection Images
Generic Name: fam-trastuzumab deruxtecan
This medication has been identified as Enhertu 100 mg lyophilized powder for injection. It is supplied by Daiichi Sankyo.
Enhertu is used in the treatment of Breast Cancer, Metastatic; Solid Tumors; Non Small Cell Lung Cancer; Breast Cancer; Gastric Cancer and belongs to the drug class HER2 inhibitors. Enhertu 100 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Enhertu
- Generic Name
- fam-trastuzumab deruxtecan
- Strength
- 100 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- HER2 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Daiichi Sankyo
- National Drug Code (NDC)
- 65597-0406
See also:
Trodelvy
Trodelvy (sacituzumab govitecan) is a targeted therapy used to treat breast cancer (triple-negative ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Verzenio
Verzenio is used to treat early and advanced-stage hormone receptor-positive, HER2-negative breast ...
Kisqali
Kisqali (ribociclib) is used to treat a certain type of advanced metastatic breast cancer. Includes ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Tafinlar
Tafinlar is a prescription medicine used to treat BRAF mutated melanoma, non-small cell lung ...
Mekinist
Mekinist is used to treat melanoma, non-small cell lung cancer, thyroid cancer, solid tumors, and ...
Rasuvo
Rasuvo is used for polyarticular juvenile idiopathic arthritis, psoriasis, rheumatoid arthritis
More about Enhertu (fam-trastuzumab deruxtecan)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (35)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: HER2 inhibitors
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.